KRSA ▼ -0.3% - Korsana Biosciences, Inc. $KRSA reported Q3 2026 EPS of -$3.19, missing the -$0.70 estimate by 355.7%. Revenue was $0. No analyst estimate was published for revenue. 05-NOV-2026 07:41 AM ET